To develop novel therapies for clinical treatments, it increasingly depends on sophisticated delivery systems that facilitate the drugs entry into targeting cells. Profound understanding of cellular uptake routes for transporting carriers promotes the optimization of performance in drug delivery systems. Although endocytic pathway is the most important part of cellular uptake routes for many delivery systems, it suffers the trouble of enzymatic degradation of transporting carriers trapped in endosomes/lysosomes. Therefore, it is desirable to develop alternative transporting methods for delivery systems via non-endocytic pathways to achieve more effective intracellular delivery. In this review, we summarize the literature exploring transport...
Therapeutic cargos which are impermeable to the cell can be delivered by cell penetrating peptides (...
AbstractDuring the last two decades, delivery has become a major challenge for the development of ne...
International audienceOne of the major challenges for new therapeutics molecules to enter the clinic...
Nanomedicine has opened the way to the design of more efficient diagnostics and therapeutics. Moreov...
The insides of cells can be viewed as a treasure trove of targets for therapeutic intervention of di...
International audienceThe recent discovery of new potent therapeutic molecules that do not reach the...
Despite the fact that non-viral nucleic acid delivery systems are generally considered to be less ef...
Cell-penetrating peptides (CPPs) can cross cellular membranes in a non-toxic fashion, improving the ...
The cell membrane is a highly selective barrier. This limits the cellular uptake of molecules includ...
Abstract: Cell-penetrating peptides (CPPs) can cross cellular membranes in a non-toxic fashion, impr...
The hydrophobic nature of cell membranes is one of the major obstacles in the therapeutic delivery o...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...
Recently, membrane-active peptides or proteins that include antimicrobial peptides (AMPs), cytolytic...
Cell-penetrating peptides (CPPs) are efficient vehicles to transport bioactive molecules into the ce...
Cellular and nuclear delivery of biomolecules is limited by low membrane permeability. Cell-penetrat...
Therapeutic cargos which are impermeable to the cell can be delivered by cell penetrating peptides (...
AbstractDuring the last two decades, delivery has become a major challenge for the development of ne...
International audienceOne of the major challenges for new therapeutics molecules to enter the clinic...
Nanomedicine has opened the way to the design of more efficient diagnostics and therapeutics. Moreov...
The insides of cells can be viewed as a treasure trove of targets for therapeutic intervention of di...
International audienceThe recent discovery of new potent therapeutic molecules that do not reach the...
Despite the fact that non-viral nucleic acid delivery systems are generally considered to be less ef...
Cell-penetrating peptides (CPPs) can cross cellular membranes in a non-toxic fashion, improving the ...
The cell membrane is a highly selective barrier. This limits the cellular uptake of molecules includ...
Abstract: Cell-penetrating peptides (CPPs) can cross cellular membranes in a non-toxic fashion, impr...
The hydrophobic nature of cell membranes is one of the major obstacles in the therapeutic delivery o...
A major obstacle in the development of new therapeutic agents is the low bioavailability of hydrophi...
Recently, membrane-active peptides or proteins that include antimicrobial peptides (AMPs), cytolytic...
Cell-penetrating peptides (CPPs) are efficient vehicles to transport bioactive molecules into the ce...
Cellular and nuclear delivery of biomolecules is limited by low membrane permeability. Cell-penetrat...
Therapeutic cargos which are impermeable to the cell can be delivered by cell penetrating peptides (...
AbstractDuring the last two decades, delivery has become a major challenge for the development of ne...
International audienceOne of the major challenges for new therapeutics molecules to enter the clinic...